Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.240 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
37 38 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining... 
Via Benzinga
BRZE Stock: 16 Reasons Why Newly Public Braze Is Bouncing Higher Today
Braze (BRZE) stock is on the move Tuesday after the company released its earnings report for the third quarter of the year. 
Via InvestorPlace
Quick Take Technical Analysis: Cassava Sciences, Inc
Cassava Sciences, Inc (NASDAQ:SAVA) fell over 5% on Tuesda... 
Via Benzinga
BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today
Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. 
Via InvestorPlace
Why Cassava Sciences Stock Is Trading Higher Today
Cassava Sciences Inc (NASDAQ: SAVA) is trading higher Tuesday after the company was informed by Neuroscience journal that there was no evidence to support data manipulation... 
Via Benzinga
SAVA Stock: The Social Media Chatter That Has Cassava Sciences Trending Today
Cassava Sciences (SAVA) stock is getting some extra attention today from traders on social media and we've got all the details. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8... 
Via Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains... 
Via Benzinga
65 Biggest Movers From Yesterday
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... 
Via Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. 
Via InvestorPlace
Exposures COVID-19
2 Big Stock Bets That Are Insiders Are Buying Now
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
CORRECTING and REPLACING CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
While Cassava Sciences Is a Risky Play, It Has Substantial Payoff Potential
Informed investors who can handle its high risk may want to take a look at speculative biotech play SAVA stock. 
Via InvestorPlace
Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ: 
Via Benzinga
Should Investors Worry About the Federal Investigation of Cassava?
The investigation really isn't the underlying concern. 
Via The Motley Fool
Cassava Sciences Just Returned to the Buy Zone
There's no need to panic about SAVA stock, as Cassava Sciences just launched an important study focused on treating Alzheimer's disease. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... 
Via Benzinga
Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam
Cassava Sciences Inc (NASDAQ: SAVA) has initiated a second Phase 3 study of simufilam in patients with Alzheimer's disease. The second Phase 3 study is... 
Via Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
But can they keep up the momentum? 
Via The Motley Fool
61 Biggest Movers From Yesterday
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
2 More Stocks Set to 2x… 5x… 10x in 2022
Finding 10x stocks is possible; it's simply a matter of knowing what patterns to look for. Here are a couple of strong contenders. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
See Why Cassava Sciences Shares Are Falling On Wednesday?
The Wall Street Journal reported that the SEC had launched a probe into claims that Cassava Sciences Inc (NASDAQ: SAVA) manipulated data key to its case for... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Cassava Sciences Is Sliding Lower Today
Allegations of data manipulation that hammered the company -- and its stock price -- this summer won't be easily forgotten. 
Via The Motley Fool
Topics Regulatory Compliance
Exposures Legal Regulatory
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYP... 
Via Benzinga
Today’s Hot Penny Stocks: What’s Moving ZSAN, AVGR and CEI Higher Wednesday?
Today's hot penny stocks are catching the eyes of investors and we're diving into everything investors need to know about them on Wednesday! 
Via InvestorPlace
ROKU Stock Price Predictions: How Low One Analyst Thinks Roku Will Go
Roku (ROKU) stock price predictions aren't doing the shares any favors on Wednesday after one analyst put out a bearish take. 
Via InvestorPlace
Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge
Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback